Latest News

SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome

July 3rd 2025

In a recent interview at the SNMMI conference, Ryota Satoh, Ph.D., discussed new positron emission tomography (PET research examining the role of neuroinflammation in differentiating between progressive apraxia of speech (PAOS) and Parkinson-plus syndrome.

Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer
Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer

July 3rd 2025

Predicting Nipple-Areolar Complex Involvement in Early-Stage Breast Cancer: Can Cone-Beam CT Have an Impact?
Predicting Nipple-Areolar Complex Involvement in Early-Stage Breast Cancer: Can Cone-Beam CT Have an Impact?

July 3rd 2025

FDA Clears Emerging 3D Ultrasound Technology
FDA Clears Emerging 3D Ultrasound Technology

July 2nd 2025

FDA Clears SmartSpeed Precise MRI Software from Philips
FDA Clears SmartSpeed Precise MRI Software from Philips

July 2nd 2025

Video Interviews

Latest Conference Coverage

View All
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome

July 3rd 2025

Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
Improving Access to Nuclear Medicine: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD

June 30th 2025

SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level

June 26th 2025

SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection

June 26th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.